These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12188240)

  • 1. A conjugate vaccine for the prevention of pediatric pneumococcal disease.
    Murray D; Jackson C
    Mil Med; 2002 Aug; 167(8):671-7. PubMed ID: 12188240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.
    Block SL; Hedrick J; Harrison CJ; Tyler R; Smith A; Findlay R; Keegan E
    Pediatr Infect Dis J; 2004 Sep; 23(9):829-33. PubMed ID: 15361721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children.
    Shields B
    J Pediatr Health Care; 2001; 15(4):203-8; quiz 209-10. PubMed ID: 11462129
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
    Moore MR; Hyde TB; Hennessy TW; Parks DJ; Reasonover AL; Harker-Jones M; Gove J; Bruden DL; Rudolph K; Parkinson A; Butler JC; Schuchat A
    J Infect Dis; 2004 Dec; 190(11):2031-8. PubMed ID: 15529269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new conjugate vaccine against pneumococcal disease.
    Wilson-Adkins M; Adkins C
    Nurse Pract; 2001 May; 26(5):52, 55-6, 59-62. PubMed ID: 11383494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates.
    Pelton SI; Loughlin AM; Marchant CD
    Pediatr Infect Dis J; 2004 Nov; 23(11):1015-22. PubMed ID: 15545856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Black S; Shinefield H; Baxter R; Austrian R; Bracken L; Hansen J; Lewis E; Fireman B
    Pediatr Infect Dis J; 2004 Jun; 23(6):485-9. PubMed ID: 15194827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.
    Pediatrics; 2000 Aug; 106(2 Pt 1):362-6. PubMed ID: 10920169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of pneumococcal disease in the United Kingdom--the start of a new era.
    Clarke SC
    J Med Microbiol; 2006 Aug; 55(Pt 8):975-980. PubMed ID: 16849715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation with a pneumococcal 7-valent conjugate vaccine.
    Dagan R
    Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis.
    Overturf GD
    Pediatrics; 2000 Aug; 106(2 Pt 1):367-76. PubMed ID: 10920170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccines: do they prevent infection and how?
    Posfay-Barbe KM; Wald ER
    Curr Opin Infect Dis; 2004 Jun; 17(3):177-84. PubMed ID: 15166818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.
    Darkes MJ; Plosker GL
    Paediatr Drugs; 2002; 4(9):609-30. PubMed ID: 12175274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.